Product Information
LOTREL 5-20 MG CAPSULE is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $12.2080 per EA under NDC 00078040605. Its NADAC has been published 425 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the amlodipine besylate and benazepril hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5; 20 mg/1; mg/1
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078040605
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
5/21/2025
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020364On Market Since
3/3/1995
Pharmacological Classes
Price Statistics
The NADAC for LOTREL 5-20 MG CAPSULE has been published 425 times since Nov 28, 2013, and over the history we have for it it has risen 145.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.2080 per EA |
|---|---|
| All-time high | $12.2266 (May 14, 2025) |
| All-time low | $4.9766 (Nov 28, 2013) |
| 52-week high | $12.2080 |
| 52-week low | $12.2080 |
| Median price | $9.1195 |
| Average price | $8.9508 |
| Largest weekly change | +25.5% (Apr 17, 2024) |
| Weeks tracked | 425 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the amlodipine besylate and benazepril hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LOTREL 5-20 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LOTREL 5-20 MG CAPSULE, manufactured by Novartis Pharmaceuticals Corporation, is $12.2080 per EA (NDC 00078040605), effective May 13, 2026.
How has the price of LOTREL 5-20 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LOTREL 5-20 MG CAPSULE has risen 145.3%. It has been tracked across 425 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LOTREL 5-20 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LOTREL 5-20 MG CAPSULE has ranged from a low of $4.9766 (Nov 28, 2013) to a high of $12.2266 (May 14, 2025), with a median of $9.1195 per EA.
Are there cheaper alternatives to LOTREL 5-20 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LOTREL 5-20 MG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures LOTREL 5-20 MG CAPSULE?
LOTREL 5-20 MG CAPSULE (NDC 00078040605) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification